Alnylam Pharmaceuticals
ALNY
#1123
Rank
C$29.97 B
Marketcap
C$223.78
Share price
3.61%
Change (1 day)
-63.88%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company